CORC

浏览/检索结果: 共96条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Anlotinib combined with induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Jiang, Feng;  Chen, Xiaozhong;  Liu, Tongxin;  Qin, WeiFeng;  Huang, Shuang
收藏  |  浏览/下载:7/0  |  提交时间:2022/12/23
Penpulimab plus gemcitabine in combination with cisplatin or anlotinib as first-line treatment for metastatic nasopharyngeal carcinoma (M NPC): A phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Huang, Shuang;  Chen, Xiaozhong;  Qu, Song;  Qu, Shenhong;  Han, Yaqian
收藏  |  浏览/下载:9/0  |  提交时间:2022/12/23
Anlotinib plus radiotherapy-temozolomide for newly diagnosed glioblastoma: A prospective, multicenter phase II study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Lai, Shuzhen;  Chen, Yuan Yuan Yuan;  Li, Peijing;  Jiang, Fagui;  Liu, Xiaohui
收藏  |  浏览/下载:11/0  |  提交时间:2022/12/23
A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft-tissue sarcoma: Updated results. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Tao;  Ye, Zhaoming;  Wei, Yongzhong;  Wang, Shoufeng;  Liu, Yunxia
收藏  |  浏览/下载:8/0  |  提交时间:2022/12/23
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan
收藏  |  浏览/下载:11/0  |  提交时间:2022/12/23
Anlotinib in Locally Advanced or Metastatic Medullary Thyroid Carcinoma: A Randomized, Double-Blind Phase IIB Trial 期刊论文
CLINICAL CANCER RESEARCH, 2021, 卷号: 27
作者:  Li, Dapeng;  Chi, Yihebali;  Chen, Xiaohong;  Ge, Minghua;  Zhang, Yuan
收藏  |  浏览/下载:29/0  |  提交时间:2021/08/31
Updated results of ALTER-C002: Anlotinib combined with CAPEOX in first-line treatment of patients with RAS/BRAF wild-type unresectable metastatic colorectal cancer. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Ding, Ke-Feng;  Liu, Yue;  Du, Jinlin;  Zhu, Yuping;  Liu, Zhuo
收藏  |  浏览/下载:30/0  |  提交时间:2022/01/10
A phase II study of anlotinib combined with STUPP regimen in the treatment of patients with newly diagnosed glioblastoma (GBM). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Peijing;  Chen, Yuan Yuan Yuan;  Lai, Shuzhen;  Jiang, Fagui;  Liu, Xiaohui
收藏  |  浏览/下载:17/0  |  提交时间:2022/01/10
A phase II study of anlotinib in the first-line treatment of locally advanced or metastatic soft tissue sarcoma. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Huang, Xin;  Ye, Zhaoming;  Li, Tao;  Wei, Yongzhong;  Wang, Shoufeng
收藏  |  浏览/下载:20/0  |  提交时间:2022/01/10
Combination of sintilimab, anlotinib and pegaspargase "sandwich" with radiotherapy in localized natural killer/T cell lymphoma: A multicenter, phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Li, Zhiming;  Sun, Peng;  Wang, Yu;  Yang, Hang;  Li, Yajun
收藏  |  浏览/下载:24/0  |  提交时间:2022/01/10


©版权所有 ©2017 CSpace - Powered by CSpace